Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03593434 · ClinicalTrials.gov registry record
Airway Clearance Therapy on Hyperpolarized 129Xenon and MRI
A clinical trial, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 20
- Enrollment target
NCT03593434 is a clinical trial that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 20 participants.
The verdict
NCT03593434 has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This is an observational cohort study building on an existing protocol at our institution recruiting CF patients who are 6-21 years old with one or two copies of the F508del CFTR mutation. That existing protocol seeks to enroll a total of 38 subjects; it includes three to four (three scheduled, with a fourth optional) study visits, with spirometry, LCI, UTE MRI, and 129Xe MRI being performed at each visit. This present study will utilize existing study visits for the NHLBI study, with a sub-set of 20 subjects opting-in to have all of the procedures performed twice, with an intervening ACT, during one of their study visits.
Interventions
- DRUG hyperpolarized Xenon gas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-07-30 |
| Est. Completion | 2021-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03593434
The ClinicalTrials.gov registry entry for NCT03593434 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which hyperpolarized Xenon gas is the first listed.
NCT03593434 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03593434 about?
NCT03593434 is a clinical study titled "Airway Clearance Therapy on Hyperpolarized 129Xenon and MRI". This is an observational cohort study building on an existing protocol at our institution recruiting CF patients who are 6-21 years old with one or two copies of the F508del CFTR mutation. That existing protocol seeks to enroll a total of 38 subjects; it includes three to four (three scheduled, with...
What is the current status of trial NCT03593434?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2018-07-30. Estimated completion is 2021-12-30.
What interventions are being tested in trial NCT03593434?
The interventions under investigation include: hyperpolarized Xenon gas (DRUG).
Who is sponsoring clinical trial NCT03593434?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.